Interestingly, a recent study identified a macrophage subset defined by FOSL2 (an AP-1 factor) activity and derived from circulating monocytes as strongly associated with glioma malignancy38, supporting our observation that AP-1–enriched monocytes are predisposed to macrophage differentiation within the tumor microenvironment. Here, FOSL2 is linked to glioma.